Comments to FDA: Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology

Share page:
Docket Number:
FDA-2010-D-0530

CHPA applauds the approach for creating a public forum to collect current research and comments to advance the science of engineered nanomaterials.

Related Posts

CHPA Statement on Valisure Citizen Petition